Antibodies against hepatitis B virus antigens (hepatitis core antigen (anti-HBc) IgG, hepatitis B specific antigen (anti-HBs) IgG and IgM, and anti-hBe IgM) have long been suspected to be predictive factors for hepatocellular carcinoma (HCC). Here, KRT88P is linked to hepatocellular carcinoma.